Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Neuropsychological pattern of Parkinson's disease

https://doi.org/10.14412/2074-2711-2017-4-82-87

Full Text:

Abstract

The review deals with the problem of neuropsychological disorders in Parkinson's disease (PD), one of the most common neurodegenerative diseases in the world. A global search for foreign and Russian investigations in this topic in 2001 to 2016 has been carried out in the scientific databases Medline and Russian science citation index. Particular emphasis is laid on emotional, cognitive, and psychotic disorders that largely worsen quality of life and cause professional and social dysadaptation. The manifestations of and diagnostic criteria for impulsivecompulsive disorders in PD and the contribution of genetic and sociodemographic factors to their genesis are also depicted. Clinical neuropsychological assessment scales are assessed. Sleep disorders that are pathogenetically similar to neuropsychological disorders are characterized.

About the Authors

A. A. Tappakhov
M.K. Ammosov North-Eastern Federal University
Russian Federation
58, Belinsky St., Yakutsk, 677000


T. E. Popova
M.K. Ammosov North-Eastern Federal University
Russian Federation
58, Belinsky St., Yakutsk, 677000


T. Ya. Nikolaeva
M.K. Ammosov North-Eastern Federal University
Russian Federation
58, Belinsky St., Yakutsk, 677000


N. A. Schnaider
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022


M. M. Petrova
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022


M. R. Sapronova
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022


References

1. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009 May;8(5):464-74. doi: 10.1016/S1474-4422(09)70068-7.

2. Иллариошкин СН. Течение болезни Паркинсона и подходы к ранней диагностике. В кн.: Болезнь Паркинсона и расстройства движений: руководство для врачей по материалам II Национального конгресса. Москва; 2011. С. 41-7. [Illarioshkin SN. The course of Parkinson's disease and approaches to early diagnosis. In: Bolezn' Parkinsona i rasstroistva dvizhenii: rukovodstvo dlya vrachei po materialam II Natsional'nogo kongressa [Parkinson's disease and movement disorders: a guidelines based on the materials of the 2nd National Congress]. Moscow; 2011. P. 41-7.]

3. Braak H, Ghebremedhin E, Rü b U, et al. Stages in the development of Parkinson’s disease- related pathology. Cell Tissue Res. 2004 Oct;318(1):121-34. Epub 2004 Aug 24.

4. Rietdijk CD, Perez-Pardo P, Garssen J, et al. Exploring Braak’s Hypothesis of Parkinson’s Disease. Front Neurol. 2017 Feb 13;8:37. doi: 10.3389/fneur.2017.00037. eCollection 2017.

5. Schrag A, Horsfall L, Walters K, et al. Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study. Lancet Neurol. 2015 Jan;14(1):57-64. doi: 10.1016/S1474-4422(14)70287-X. Epub 2014 Nov 27.

6. Нодель МР, Яхно НН. Нервно-психические нарушения при болезни Паркинсона. Неврология, нейропсихиатрия, психосоматика. 2009;1(2):3-8. [Nodel' MR, Yakhno NN. Nervous and mental disorders in Parkinson's disease. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2009;1(2):3-8. (In Russ.)]. doi:10.14412/2074-2711-2009-30.

7. Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Mov Disord. 2010 Nov 15;25(15): 2493-500. doi: 10.1002/mds.23394.

8. Нодель МР. Депрессия при болезни Паркинсона. Неврология, нейропсихиатрия, психосоматика. 2010;2(4):11-7. [Nodel MR. Depession in Parkinson's disease. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):11-7. (In Russ.)]. doi: 10.14412/2074-2711-2010-110.

9. Федорова НВ, Кулуа ТК. Депрессия при болезни Паркинсона. Альманах клинической медицины. 2005;8(3):117-9. [Fedorova NV, Kulua TK. Depession in Parkinson's disease. Al'manakh klinicheskoi meditsiny. 2005;8(3):117-9 (In Russ.)].

10. Залялова ЗА, Хасанова ДМ. Депрессия у пациентов с ранними стадиями болезни Паркинсона. Трудный пациент. 2016;14 (4-5):22-8. [Zalyalova ZA, Khasanova DM. Depression in early stages of Parkinson’s disease. Trudnyi patsient. 2016;14(4-5):22-8. (In Russ.)].

11. Ketharanathan T, Hanwella R, Weerasundera R, et al. Major depressive disorder in Parkinson’s disease: a cross-sectional study from Sri Lanka. BMC Psychiatry. 2014 Sep 30;14:278. doi: 10.1186/s12888-014-0278-8.

12. Яхно НН, Нодель МР. Особенности депрессии при болезни Паркинсона. Доктор.ру. 2013;(5):50-4. [Yakhno NN, Nodel' MR. Features of depression in Parkinson's disease. Doktor.ru. 2013;(5):50-4. (In Russ.)].

13. Вереютина ИА, Иллариошкин СН, Журавлева ЕЮ и др. Нейропсихологические расстройства на ранней стадии болезни Паркинсона. Анналы клинической и экспериментальной неврологии. 2012;6(2):11-5. [Vereyutina IA, Illarioshkin SN, Zhuravleva EYu, et al. Neuropsychological disturbances in eary stage of Parkinson's disease. Annaly klinicheskoi i eksperimental'noi nevrologii. 2012;6(2):11-5. (In Russ.)].

14. Torbey E, Pachana NA, Dissanayaka NN. Depression rating scales in Parkinson’s disease: A critical review updating recent literature. J Affect Disord. 2015 Sep 15;184:216-24. doi: 10.1016/j.jad.2015.05.059. Epub 2015 Jun 10.

15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. 2013. 991 p.

16. Dissanayaka NN, White E, O’Sullivan JD, et al. The clinical spectrum of anxiety in Parkinson’s disease. Mov Disord. 2014 Jul; 29(8):967-75. doi: 10.1002/mds.25937.

17. Dissanayaka NN, Torbey E, Pachana NA. Anxiety rating scales in Parkinson’s disease: a critical review updating recent literature. Int Psychogeriatr. 2015 Nov;27(11):1777-84. doi: 10.1017/S1041610215000885.Epub 2015 Jun 23.

18. Левин ОС. Болезнь Паркинсона как нейропсихиатрическое заболевание. В кн: Болезнь Паркинсона и расстройства движений: руководство для врачей по материалам II национального конгресса. Москва; 2011. С. 99-104. [Levin OS. Parkinson's disease like neuropsychiatric disease. In: Bolezn' Parkinsona i rasstroistva dvizhenii: rukovodstvo dlya vrachei po materialam II natsional'nogo kongressa [Parkinson's disease and movement disorders: a guidelines based on the materials of the 2nd National Congress]. Moscow; 2011. P. 99-104.]

19. Benito-Leon J, Cubo E, Coronell C. Impact of apathy on health-related quality of life in recently diagnosed Parkinson’s disease: the ANIMO study. Mov Disord. 2012 Feb;27(2): 211- 8. doi: 10.1002/mds.23872. Epub 2011 Jul 20.

20. Cummings J, Friedman JH, Garibaldi G, et al. Apathy in Neurodegenerative Diseases. J Geriatr Psychiatry Neurol. 2015 Sep;28(3): 159-73. doi: 10.1177/0891988715573534. Epub 2015 Mar 24.

21. Aarsland D, Bronnick K, Alves G, et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):928-30. doi: 10.1136/jnnp.2008.166959.

22. Cubo E, Benito-Leen J, Coronell C, et al. Clinical correlates of apathy in patients recently diagnosed with parkinson’s disease: The ANIMO Study. Neuroepidemiology. 2012;38(1):48- 55. doi: 10.1159/000334314. Epub 2012 Jan 6.

23. Robert PH, Berr C, Volteau M, et al. Importance of lack of interest in patients with mild cognitive impairment. Am J Geriatr Psychiatry. 2008 Sep;16(9):770-6. doi: 10.1097/JGP.0b013e31817e73db.

24. Нодель МР, Яхно НН. Апатия при болезни Паркинсона. Неврологический журнал. 2014;(1):9-15. [Nodel' MR, Yakhno NN. Apathy in Parkinson's disease. Nevrologicheskii zhurnal. 2014;(1):9-15. (In Russ.)]. doi: 10.18821/1560-9545-2014-19-1-9-15.

25. Weintraut R, Karаdi K, Lucza T, et al. Lille Apathy Rating Scale and MDS-UPDRS for Screening Apathy in Parkinson’s Disease. J Parkinsons Dis. 2016;6(1):257-65. doi: 10.3233/JPD-150726.

26. Foltynie T, Brayne CE, Robbins TW, et al. The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study. Brain. 2004 Mar;127(Pt 3): 550-60. Epub 2003 Dec 22. doi:10.1093/brain/awh067.

27. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012 Mar;27(3):349-56. doi: 10.1002/mds.24893. Epub 2012 Jan 24.

28. Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord. 2008 Apr 30; 23(6):837-44. doi: 10.1002/mds.21956.

29. Dirnberger G, Jahanshahi M. Executive dysfunction in Parkinson’s disease: A review. J Neuropsychol. 2013 Sep;7(2):193-224. doi: 10.1111/jnp.12028.

30. Kalbe E, Rehberg SP, Heber I, et al. Subtypes of mild cognitive impairment in patients with Parkinson’s disease: evidence from the LANDSCAPE study. J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1099-105. doi: 10.1136/jnnp-2016-313838. Epub 2016 Jul 8.

31. Chou KL, Amick MM, Brandt J, et al. A recommended scale for cognitive screening in clinical trials of Parkinson’s disease. Mov Disord. 2010 Nov 15;25(15):2501-7. doi: 10.1002/mds.23362.

32. Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009 Nov 24;73(21):1738-45. doi: 10.1212/WNL.0b013e3181c34b47.

33. Levin J, Hasan A, Hö glinger GU. Psychosis in Parkinson’s disease: identification, prevention and treatment. J Neural Transm (Vienna). 2016 Jan;123(1):45-50. doi: 10.1007/s00702-015-1400-x. Epub 2015 Apr 18.

34. Rongve A, Auning E, Ehrt U, et al. Psychosis in Parkinson’s disease. Tidsskr Nor Laegeforen. 2012 Jan 24;132(2):155-8. doi: 10.4045/tidsskr.11.0723.

35. Аникина МА, Васенина ЕЕ, Левин ОС. Психотические нарушения при болезни Паркинсона. В кн: Болезнь Паркинсона и расстройства движений: руководство для врачей по материалам III Национального конгресса. Москва; 2014. С. 94-5. [Anikina MA, Vasenina EE, Levin OS. Psychotic distubances in Parkinson's disease. In: Bolezn' Parkinsona i rasstroistva dvizhenii: rukovodstvo dlya vrachei po materialam III natsional'nogo kongressa [Parkinson's disease and movement disorders: a guidelines based on the materials of the 3rd National Congress]. Moscow; 2014. P. 94-5.]

36. Harding AJ, Stimson E, Henderson JM, et al. Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease. Brain. 2002 Nov;125(Pt 11):2431-45.

37. Ferreri F, Agbokou C, Gauthier S. Recognition and management of neuropsychiatric complications in Parkinson’s disease. CMAJ. 2006 Dec 5;175(12):1545-52. doi:10.1503/cmaj.060542.

38. Papapetropoulos S, Mash DC. Psychotic symptoms in Parkinson’s disease. From description to etiology. J Neurol. 2005 Jul;252(7): 753-64. doi:10.1007/s00415-005-0918-5.

39. Fenelon G, Goetz CG, Karenberg A. Hallucinations in Parkinson disease in the prelevodopa era. Neurology. 2006 Jan 10; 66(1):93-8. doi:10.1212/01.wnl.0000191325.31068.c4.

40. Левин ОС, Аникина МА. Психотические нарушения при болезни Паркинсона и деменции с тельцами Леви. В кн: Болезнь Паркинсона и расстройства движений: руководство для врачей по материалам II Национального конгресса. Москва; 2011. С. 76-9. [Levin OS, Anikina MA. Psychotic disturbances in Parkinson's disease and dementia with Lewy bodies. In: Bolezn' Parkinsona i rasstroistva dvizhenii: rukovodstvo dlya vrachei po materialam II natsional'nogo kongressa [Parkinson's disease and movement disorders: a guidelines based on the materials of the 2nd National Congress]. Moscow; 2011. P. 76-9.]

41. Fenelon G, Alves G. Epidemiology of psychosis in Parkinson’s disease. J Neurol Sci. 2010 Feb 15;289(1-2):12-7. doi: 10.1016/j.jns.2009.08.014. Epub 2009 Sep 8.

42. Dagher A, Robbins TW. Personality, Addiction, Dopamine: Insights from Parkinson’s Disease. Neuron. 2009 Feb 26;61(4): 502-10. doi: 10.1016/j.neuron.2009.01.031.

43. Antonini A, Siri C, Santangelo G, et al. Impulsivity and compulsivity in drug-naive patients with Parkinson’s disease. Mov Disord. 2011 Feb 15;26(3):464-8. doi: 10.1002/mds.23501. Epub 2011 Feb 10.

44. Maier F, Merkl J, Ellereit AL, et al. Hypomania and mania related to dopamine replacement therapy in Parkinson’s disease. Parkinsonism Relat Disord. 2014 Apr;20(4): 421- 7. doi: 10.1016/j.parkreldis.2014.01.001. Epub 2014 Jan 12.

45. Cormier F, Muellner J, Corvol JC. Genetics of impulse control disorders in Parkinson’s disease. J Neural Transm (Vienna). 2013 Apr; 120(4):665-71. doi: 10.1007/s00702-012-0934- 4. Epub 2012 Dec 12.

46. Bastiaens J, Dorfman BJ, Christos PJ, et al. Prospective cohort study of impulse control disorders in Parkinson’s disease. Mov Disord. 2013 Mar;28(3):327-33. doi: 10.1002/mds.25291. Epub 2013 Jan 2.

47. Weintraub D, Papay K, Siderowf A. Screening for impulse control symptoms in patients with de novo Parkinson disease: A casecontrol study. Neurology. 2013 Jan 8;80(2):176-80. doi: 10.1212/WNL.0b013e31827b915c.

48. Hassan A, Bower JH, Kumar N, et al. Dopamine agonist-triggered pathological behaviors: Surveillance in the PD clinic reveals high frequencies. Parkinsonism Relat Disord. 2011 May;17(4):260-4. doi: 10.1016/j.parkreldis.2011.01.009. Epub 2011 Feb 9.

49. Сапронова МР, Шнайдер НА. Предикторы и модификаторы импульсивно-компульсивных расстройств при болезни Паркинсона. Журнал неврологии и психиатрии им. С.С. Корсакова. 2016;(11):110-21. [Sapronova MR, Shnaider NA. Predictors and modificators of impulsive and compulsive disorders in Parkinson’s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016;(11):110-21. (In Russ.)].

50. Adler CH, Thorpy MJ. Sleep issues in Parkinson’s disease. Neurology. 2005 Jun 28;64(12 Suppl 3):S12-20.

51. Ylikoski A, Martikainen K, Sieminski M, et al. Parkinson’s disease and insomnia. Neurol Sci. 2015 Nov;36(11):2003-10. doi: 10.1007/s10072-015-2288-9. Epub 2015 Jun 23.

52. Knie B, Mitra MT, Logishetty K, et al. Excessive daytime sleepiness in patients with Parkinson’s disease. CNS Drugs. 2011 Mar; 25(3):203-12. doi: 10.2165/11539720-000000000-00000.

53. Доронина КС, Доронина ОБ, Иллариошкин СН и др. Нарушение поведения в REM- фазе сна как диагностический маркер ранней стадии болезни Паркинсона. Неврология и нейрохирургия Восточная Европа. 2016;(4):555-9. [Doronina KS, Doronina OB, Illarioshkin SN, et al. Disturbance of behavior in REM-sleep as a diagnostic marker of the

54. early stage of Parkinson's disease. Nevrologiya i neirokhirurgiya Vostochnaya Evropa. 2016; (4): 555-9. (in Russ.)].

55. Красаков ИВ, Литвиненко ИВ. Расстройства фазы быстрого сна при болезни Паркинсона – диагностика и способы терапии. В кн: Болезнь Паркинсона и расстройства движений: руководство для врачей по материалам III Национального конгресса. Москва; 2014. С. 116-9. [Krasakov IV, Litvinenko IV. Disorders of the fast sleep phase in Parkinson's disease - diagnosis and therapy. In: Bolezn' Parkinsona i rasstroistva dvizhenii: rukovodstvo dlya vrachei po materialam III natsional'nogo kongressa [Parkinson's disease and movement disorders: a guidelines based on the materials of the 3rd National Congress]. Moscow; 2014. P. 116-9.]

56. Romenets SR, Gagnon JF, Latreille V, et al. Rapid eye movement sleep behavior disorder and subtypes of Parkinson’s disease. Mov Disord. 2012 Jul;27(8):996-1003. doi: 10.1002/mds.25086. Epub 2012 Jun 25.

57. Postuma RB, Lang AE, Massicotte-Marquez J, et al. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology. 2006 Mar 28;66(6):845-51. doi:10.1212/01.wnl.0000203648.80727.5b.

58. Литвиненко ИВ, Красаков ИВ, Тихомирова ОВ. Нарушения сна при болезни Паркинсона: патофизиологические механизмы, клинические варианты и направления коррекции. В кн: Болезнь Паркинсона и расстройства движений: руководство для врачей по материалам II Национального конгресса. Москва: 2011. С. 93-8. [Litvinenko IV, Krasakov IV, Tikhomirova OV. Sleep disorders in Parkinson's disease: pathophysiological mechanisms, clinical variants and directions of correction. Bolezn' Parkinsona i rasstroistva dvizhenii: rukovodstvo dlya vrachei po materialam II natsional'nogo kongressa [Parkinson's disease and movement disorders: a guidelines based on the materials of the 2nd National Congress]. Moscow; 2011. P. 93-8.]

59. Postuma RB, Arnulf I, Hogl B, et al. A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord. 2012 Jun;27(7):913-6. doi: 10.1002/mds.25037. Epub 2012 May 30.

60. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006 Jul;21(7):916-23. doi:10.1002/mds.20844.


For citation:


Tappakhov A.A., Popova T.E., Nikolaeva T.Y., Schnaider N.A., Petrova M.M., Sapronova M.R. Neuropsychological pattern of Parkinson's disease. Neurology, Neuropsychiatry, Psychosomatics. 2017;9(4):82-87. (In Russ.) https://doi.org/10.14412/2074-2711-2017-4-82-87

Views: 211


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)